An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries

Microbial Drug Resistance

Volumn 10, Issue 2, 2004, Pages 169-176

  Westh, Henrik ^a,b   Zinn, Christina Scheel ^a,b   Rosdahl, Vibeke Thamdrup ^a   Couto, E ^c   Struelens, M ^d   MacGowan, A ^e   Meurman, O ^f   Etienne, J ^g   Milatovic, D ^h   Wallrauch, C ^h   Paniara, O ⁱ   Udo, E E ^j   Miciulleviciene J ^k   Yasin, R ^l   Cowley, N ^m   Lang, S ^m   Hofstad, T ⁿ   Digranes, A ⁿ   Mlynarczyk, G ^o   Duse, A G ^p   Marco, F ^q   Trilla, T ^q   Walder, M ^r   Laurell, H ^r   Bruckner, D A ^s   Wilson, M L ^p   Weinstein, M P ^t   Pearman, J W ^u   Coombs, G ^u   more..

^a HVIDOVRE HOSPITAL   (Denmark)

^b Staphylococcus Laboratory   (Denmark)

^c HOSPITAL F J MUÑIZ   (Argentina)

^d ERASME HOSPITAL   (Belgium)

^e SOUTHMEAD HOSPITAL   (United Kingdom)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

^g LOUIS PRADEL HOSPITAL   (France)

^h Inst F Med Mikrobiol I   (Germany)

ⁱ EVANGELISMOS HOSPITAL   (Greece)

^j KUWAIT UNIVERSITY   (Kuwait)

^k Kaunas Academic Clinics   (Lithuania)

^l Bacteriology Division Jalan Pahang   (Malaysia)

^m MIDDLEMORE HOSPITAL   (New Zealand)

ⁿ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^o MEDICAL UNIVERSITY OF WARSAW   (Poland)

^p SAIMR ^*  (United States)

^q HOSPITAL CLÍNIC   (Spain)

^r Malmö Almänna Sjukhus   (Sweden)

^s UCLA MEDICAL CENTER   (United States)

^t ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^u ROYAL PERTH HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; GLYCOPEPTIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE; MEROPENEM; METICILLIN; PENICILLIN DERIVATIVE; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CORRELATION FUNCTION; DRUG USE; HOSPITAL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; GEOGRAPHY; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 3042729885     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/1076629041310019     Document Type: Article

References (35)

1. Amorim, M.L., M. Aires de Sousa, I.S. Sanches, R. Sa-Leao, J.M. Cabeda, J.M. Amorim, and H. de Lencastre. 2002 Clonal and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) from a Portuguese hospital over time. Microb. Drug Resist. 8:301-309.
2. Ayliffe, G.A.J. 1997. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. CID 24(Suppl 1):S74-S79.
3. Blumberg, H.M., D. Rimland, D.J. Carroll, P. Terry, and I.K. Wachsmuth. 1991. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J. Infect. Dis. 163:1279-1285.
4. Cars, O., S. Molstad, and A. Melander. 2001 Variation in antibiotic use in the European Union. Lancet 357:1851-1853.
5. CDC. Promoting appropriate antibiotic use in the community. 2003. http://www.cdc.gov/drugresistance/community/.
6. CDC. 2002. Campaign to Prevent Antimicrobial Resistance in Healthcare Settings http://www.cdc.gov/drugresistance/healthcare/default.htm.
7. Cosgrove, S.E., G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36:53-59.
8. Crowcroft, N.S., O. Ronveaux, D.L. Monnet, and R. Mertens. 1999. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect. Control Hosp. Epidemiol. 20:31-36.
9. Diekema, D.J., M.A. Pfaller, F.J. Schmidt, J. Smayevsky, J. Bell, R.N. Jones, M. Beach, and the Sentry Participants Group. 2001. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific for the Sentry Antimicrobial Surveillance Program 1997-1999. CID 32:S114-S132.
10. Diekema, D.J., M.A. Pfaller, J. Turnidge, J. Verhoef, J. Bell, A.C. Fluit, G.V. Doern, R.N. Jones, and the Sentry Participants Group. 2000. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. Microb. Drug. Resist. 6:213-221.
11. Fey, P.D., B. Said-Salim, M.E. Rupp, S.H. Hinrichs, D.J. Boxrud, C.C Davis, B.N. Kreiswirth, and P.M. Schlievert. 2003. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:196-203.
12. Fluit, A.C., C.L.C. Wielders, J. Verhoef, and F.-J. Schmitz. 2001. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J. Clin. Microbiol. 10:3727-3732
13. http://www.who.int/emc/amrpdfs/ interventions_against_antimicrobial_resistance.pdf.
14. http://www.who.int/emc/amrpdfs/ Antimicrobial_resistance_recommendations_of_expert_polic.pdf.
15. Kolmos, H.J. 1993. Hvidovre Hospital. Measures to control the spread of imported multiresistant Staphylococcus aureus [Article in Danish.] Nord. Med. 108:286-288.
16. McGowan, J.E., Jr. 1983. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev. Infect. Dis. 5:1033-1048
17. McGowan, J.E., Jr. 1987. Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull. N.Y. Acad. Med. 63:253-268
18. Mevius, D.J., M.J.W. Springer, and H.C. Wegener. 1999. EU conference "The Microbial Threat". Int. J. Antimicrob. Agents 11:101-105.
19. Monnet, D.L. 1998. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect. Control Hosp. Epidemiol. 19:552-559.
20. NNIS ICU Surveillance. 1999. Selected antimicrobial resistant pathogens associated with nosocomial infections in ICU patients. http://www.cdc.gov/ ncidod/hip/NNIS/ar_surv99.pdf.
21. Roberts, R.B., A. de Lencastre, W. Eisner, E.P. Severina, B. Shopsin, B.N. Kreiswirth, A. Tomasz, and the MRSA Collaborative Study Group. 1998. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. J. Infect. Dis. 178:164-171.
22. Rosdahl, V.T., and A.M. Knudsen. 1991. The decline in methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol. 12:83-88.
23. Seppala, H., T. Klaukka, R. Lehtonen, E. Nenonen, and P. Huovinen. 1995. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin. Infect. Dis. 21:1378-1385.
24. Struelens, M.J., O. Ronveaux, B. Jans, and R. Mertens. 1996. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Groupement pour le Depistage, l'Etude et la Prevention des Infections Hospitalieres. Infect. Control Hosp. Epidemiol. 17:503-508.
25. Turnidge, J.D., and J.M. Bell. 2000. Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 years. Microb. Drug Resist. 6:223-229
26. Voss, A., D. Milatovic, C. Wallrauch-Schwarz, V.T. Rosdahl, and I. Braveny. 1994. Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13:50-55
27. Vriens, M., H. Blok, A. Fluit, A. Troelstra, C. van der Werken, and J.D. Verhoef. 2002. Cost associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center. Eur. J. Clin. Microbiol. Infect. Dis. 21:782-786.
28. WHO. 2001. WHO global strategy for containment of antimicrobial resistance. http://www.who.int/emc/amrpdfs/WHO_Global_ Strategy_English.pdf.
29. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd/.
30. Widmer, A.F., H. Sax, and D. Pittet. 1999. Infection control and hospital epidemiology outside the United States. Infect. Control Hosp. Epidemiol. 20:17-21.
31. Witte, W., C. Braulke, D. Heuck, and C. Cuny. 1994. Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene. Infection 22(Suppl 2):S128-S134.
32. Witte, W. 1999. Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J. Antimicrob. Chemother. 44(Suppl A):1-9.
33. Witte, W., C. Braulke, C. Cuny, D. Heuck, and M. Kresken. 2001. Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals. Infect. Control Hosp. Epidemiol. 22:683-686.
34. Zinn, C.E., H. Westh, V.T. Rosdahl, and the SARISA Study Group. 2004. An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb. Drug Resist. 10:160-168.
35. Lipsitch, M., and M.H. Samore. 2002. Antimicrobial use and antimicrobial resistance: A population perspective. Emerg. Infect. Dis. 8:347-354.